Abstract: FR-PO866
Optimising COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy
Session Information
- Diversity and Equity in Kidney Health - II
November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Diversity and Equity in Kidney Health
- 800 Diversity and Equity in Kidney Health
Authors
- Poulikakos, Dimitrios J., Northern Care Alliance NHS Foundation Trust, Salford, Manchester, United Kingdom
- Chinnadurai, Rajkumar, Northern Care Alliance NHS Foundation Trust, Salford, Manchester, United Kingdom
- O'riordan, Edmond, Northern Care Alliance NHS Foundation Trust, Salford, Manchester, United Kingdom
- Middleton, Rachel, Northern Care Alliance NHS Foundation Trust, Salford, Manchester, United Kingdom
Background
COVID-19 vaccine hesitancy has been asscociated with social deprivation and selected minority ethnic groups who are over-represented in the Renal Replacement Therapy (RRT) population. We designed a COVID-19 vaccination programme for our RRT population with the aim to increase vaccination uptake and decrease health inequalities.
Methods
Key interventions included addressing vaccine hesitancy by deploying the respective clinical teams as trusted messengers, prompt eligible patient identification and notification, deployment of resources to optimise vaccine administration in a manner convenient to patients and timely collection and analysis of local safety and efficacy data. First COVID-19 vaccination uptake data in relation to ethnicity and social deprivation, measured by the multiple deprivation index, in our RRT population were analysed and compared with uptake data in the regional total adult clinically extremely vulnerable (CEV) population in Greater Manchester (GM). Univariate logistic regression analysis was used to explore the factors associated with not receiving a vaccine.
Results
Out of 1156 RRT patients included in this analysis (Table) 96.7% received the first dose vaccination compared to 93% in the cohort of CEV patients in the GM. Age, sex, ethnicity and index of multiple deprivation were not associated with first dose vaccine uptake. Vaccine uptake in Asian and Black RRT patients was 94.9% and 92.3% respectively compared to 93% and 76.2% for the same ethic groups in the reference CEV GM. Vaccine uptake was 96.1% of RRT patients in lowest quartile of multiple deprivation index compared to 90.5% in the GM reference population.
Conclusion
Bespoke COVID-19 vaccination programme based on local clinical teams as trusted messengers can address vaccine hesitancy and reduce health inequalities.